General NewsNews

FDA strike on batches of coagulated evaporated milk products from Nestle after consumer outcry

The Food and Drugs Authority (FDA) has begun recalling some batches of Nestle Ghana’s evaporated milk from markets across the country following complaints from customers.

In a press release, the FDA revealed that it had undertaken a comprehensive regulator action to ascertain why customers’ milk was coagulated despite not being expired.

The Authority said the root cause analysis indicated that the skimmed milk powder, the raw material used to produce the milk complained of, has poor heat stability.

“This results in the denaturing of the protein leading to the coagulation of the milk. Denatured protein, however, poses no health risk. The analysis also confirmed that there was no leaching of dangerous chemicals from the inner (lacquer) lining into the milk product,” parts of the statement read.

The FDA added that it found no microbial contamination of the samples, and thus there is no food safety issue.

But following the analysis, batches of evaporated milk manufactured with the affected raw material are being recalled.

“As of January 9, 2022, a total of 57,938 cans of the products have been retrieved by Nestle nationwide. The process is being monitored by the FDA. Therefore, anybody in possession of Ideal and Carnation milk with the batch numbers listed above should return them to Nestle or any FDA offices nationwide,” they added.

This follows complaints from numerous Nestle milk (Ideal and Carnation) consumers about buying tins of coagulated milk.

Meanwhile, the FDA has commended consumers for their alertness and encouraged them to continue reporting issues observed with any of its regulated products for the appropriate regulatory measures to be taken to ensure the health and safety of the public.

“The FDA assures the public that its Industrial Support Department continues to work with Nestle to ensure that the quality defect would not recur,” they added.

Show More

Related Articles

Leave a Reply

Back to top button